However, none of the vaccine trials have passed large-scale, late-stage phase 3 clinical trials, a necessary step before getting regulatory approval for sale.
IMBCAMS began on Saturday a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing in humans, following an on-going phase-1 study that has recruited about 200 participants since May, the institute said on Sunday in its social media channel.
The phase-2 trial will determine the shot's dose and continue to evaluate whether the potential vaccine can safely trigger immune responses in healthy people.
IMBCAMS said it expects to use a plant dedicated to producing a coronavirus vaccine this year to prepare for China's future vaccine supplies.
As early as by the end of 2020, certain groups of people with special needs can use experimental vaccines under urgent circumstances, Gao Fu, director at the Chinese Center for Disease Control and Prevention, said last month.
The coronavirus, which was first detected in China late in 2019, has infected 8.81 million people globally and killed more than 460,000 people.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
China certifies homegrown C919 jet to compete with Boeing, Airbus
China, India call for negotiated way out of Ukraine war
Chinese cities halt flights, trains as Typhoon Muifa nears
China earthquake death toll rises to 74
China launches new satellites
Southwest China's earthquake death toll rises to 46
16 killed, dozens missing in northwest China floods
China conducts drills around Taiwan as US lawmakers visit
China conducts fresh drills around Taiwan as US lawmakers visit